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Mutants of Escherichia coli (pdx B and pdx C) which are blocked in the biosynthesis of pyridoxol (vitamin B6) showed a growth response to 
4-hydroxy-L-threonine. This observation constitutes the first direct evidence in support of the view that 4-hydroxy-L-threonine is implicated in the 
biosynthesis of vitamin B,. I-Aminopropan-2,3-diol, the decarboxylation product of 4-hydroxy-L-threonine, does not support the growth of these 
mutants. Deuterium from deuterium-labelled I-aminopropan-2,3-diol was not incorporated into pyridoxol. 
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1. INTRODUCTION 
The C,-unit, C-S,-5,-6, of pyridoxol (vitamin B, (2, 
Scheme 1, originates from two independent sources: it 
is generated either from glycerol via glyceraldehyde 
phosphate [l-3] or, alternatively, from glycolaldehyde 
plus glycine [4-61. In order to rationalize this dichotomy 
of origin in terms of a common intermediate, we sug- 
gested [7] that 1-aminopropan-2,3-diol (4; Scheme 1) 
might lie on the pathway. This compound is an attrac- 
tive candidate for intermediacy, since it could arise, on 
the one hand, from glyceraldehyde phosphate by tran- 
samination followed by phosphate ester hydrolysis, and 
on the other hand from 4-hydroxy-L-threonine’ (3, 
Scheme 1) by decarboxylation [7]. 4-Hydroxy-L-threon- 
ine, whose origin, by aldolase type condensation of gly- 
colaldehyde and glycine, closely parallels the origin of 
L-serine from formaldehyde and glycine, has been de- 
tected in Streptomyces fradiae [S] and Streptomyces sp. 
#l-l (HLR 330 A) [9]. 
We now report the results of experiments designed to 
test the possible role of 1-aminopropan-2,3-diol (4, 
Scheme 1) and 4-hydroxy-L-threonine (3, Scheme 1) in 
the biosynthesis of vitamin B,. The evidence here pre- 
sented supports the view that 4-hydroxy-L-threonine is 
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indeed an intermediate of pyridoxol biosynthesis, 
whereas 1-aminopropan-2,3-diol is not. 
2. MATERIALS AND METHODS 
2.1. Growth of mutants in the presence of pyridoxal or I-hydroxy+ 
threonine (3, Scheme I) or I-aminopropan-2,3-diol (DL-~, 
Scheme 1) 
Mutants of linkage groups pdx A (WC 25 [lo]), pdx B (WC 3 [lo], 
WC 1012 [ll]), pdx C (WC 1145 [12], AT 3143 [13]) and pdx J (AT 
3208 [13]) were grown m 50 ml M9 minimal medium (6.8 g Na2HP0,, 
3.0 g KH,P04, 0.5 g NaCI, 1.0 g NH&l, 20 ml 20% glucose solution, 
1 ml MgSO, (1 M), 1 ml CaCI, (0.1 M), 1 mg pyridoxal-5’-phosphate 
in I litre of Hz0 (pH 7.0) containing the following additives: 
WC 3 (pdx B): no additives 
WC 1012 (pdx B): 20 &ml hi&dine 
WC 1145 (pdx C): 20 &ml serine 
AT 3143 (pdx C): 2Opg/ml each of histidine, proline, methlonine, 
isoleucine, valine and serine 
WC 25 (pdx A): no additives 
AT 3208 (pdx J): 1 @ml thiamine 
The bacteria were grown up to the late logarithmic growth phase 
and collected by low speed centrifugation at room temperature. The 
pellet was washed twice with an aqueous NaCl solution (0.14 M). The 
cells were suspended in 20 ml M9 medium (SO’C) without pyridoxal- 
5’-phosphate containing agar (1.6%) and triphenyltetrazolium dichlo- 
ride (2.0 mg) and the appropriate additive for each strain (see above). 
The suspension was poured into a Petri dish and, after solidification, 
wells (9 mm diameter) were pierced into the agar with a sterile cork 
borer. Aqueous solutions (100~1) of either DL-1 aminopropan-2,3-diol 
(1, 5, 10, 50, 100 nmol) or 4-hydroxy+threonine (1, 5, 10, 50, 100 
nmol) or pyridoxal (1, 5, 10, 50 nmol) were placed into individual 
wells. The growth zone (distance between rim of the well and periphery 
of the growth circle) was determined after incubation at 37°C for 12 
h. Each of the growth curves presented in Fig. 1 represents the mean 
of three independent experiments. 
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Scheme 1. o-1-Deoxyxylulose (1) and 4-hydroxy+threonme (3) precursors of pyridoxol (2). I-Aminopropan-2,3-diol (4) the decarboxylation 
product of 3, is not a precursor of pyrrdoxol. 
2.2. Synthesis of DL-[1,1,2,3,3-‘H,]-I-aminopropan-2.3-dial (9, 
Scheme 2) 
2.2.1. oL-[4,4’,4’,5,5-ZH,]-4-Hydroxymethyl-2,2-dimethyl-l,3-di- 
oxolane 
Synonyms: oL-[1,1,2,3,3-2Hj]-1,2-O-isopropylideneglycerol, [4,4’-, 
4’,5,5-*H,]solketal) (6, Scheme 2). 
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Fig. 1. Growth response to pyridoxal and to 4-hydroxy-L-threonine 
of (a) mutants of linkage groups pdx B (WG 3, WG 1012) and (b) 
mutants of linkage group pdx C (WG 1145, AT 3143). (a) q , WG 3 
with pyridoxal; +, WG 3 with 4-hydroxy-L-threonme: x, WG 1012 
with pyridoxal; A, WG 1012 with 4-hydroxy-L-threonine. (b) x, WG 
1145 with pyridoxal; A, WG 1145 with 4-hydroxy-r_-threonine: q , AT 
3143 with pyridoxal; +, AT 3143 with 4-hydroxy-L-threonine. 
To a solution of [1,1,2,3,3-2H,Jglycerol (97.7 atom % ‘H, MSD 
Isotopes) (2.5 g, 25.8 mmol) (5, Scheme 2) in acetone (25 ml) was 
added 2,2_diethoxypropane (3.75 ml), followed by p-toluenesulfonic 
acid monohydrate (63 mg). The mixture was stirred vigorously at 
room temperature for I h during which trme the progress of the 
reaction was monitored by thin layer chromatography (TLC) (SIO~, 
ether). When the conversion appeared to be complete the reaction was 
stopped by addition, to neutrality, of a solution of sodium methoxrde 
in dry methanol. (Prolonged reaction leads to isomerizatron to the 
undesired 2,2-dimethyl-5-hydroxy-1.3-dioxane, i. . 1,3-O-isopro- 
pylideneglycerol(10, Scheme 2). The reaction mixture was evaporated 
in vacua and the residue purified by bulb-to-bulb distillation at 130°C 
and 11 mm. Yield of 6, Scheme 2: 3.44 g. 95%. 
2.2.2. o~-[4,4’,4’,5,5-‘H,]-4-Aminomethyl-2,2-dimethyl-1.3-dioxolane 
(8. Scheme 2) 
The above compound (6, Scheme 2) (3.43 g, 25 mmol) was dissolved 
in dry benzene (30 ml) in a 250 ml flask. Triphenylphosphine (7.2 g, 
27.5 mmol, 1 .l equivs.) was added, followed by a solution of hydrazorc 
acid (caution, highly toxic) in dry benzene (30 ml. 1.32 mmol HN, per 
ml). The mixture was cooled to 0°C under Nz gas and a solution of 
diethyl azodicarboxylate (5.2 g, 30 mmol, 1.2 equivs.) m dry benzene 
(30 ml) was added with stirring under N? at 0°C. After the vigorous 
evolution of gas had subsided, the cooling bath was removed and the 
solutron was stirred at room temperature overnight. The solution was 
concentrated in vacua and the semi-solid residue applied to a sihca 
column. The product was eluted with light petroleum/ether l:l, the 
combined fractions containing the product were evaporated m vacua 
and the residual oily azide (7. Scheme 2) used without further purifica- 
tion. 
The crude azrde (7, Scheme 2) was dissolved in dry ether (I 5 ml) and 
the solution was added dropwise to a stirred suspension of LiAlH, (2 
g) in dry ether (125 ml). The mixture was refluxed 2.5 h, stirred at room 
temperature overnight and then decomposed. by addition of water (2 
ml) followed by aqueous odium hydroxide (15%, 2 ml) and water (6 
ml). The mrxture was boiled under reflux for 15 mm, the supernatant 
was decanted and the solid residue extracted twice under reflux for I5 
mm with dry ether (2 x 80 ml). The combined extracts were dried 
(anhydrous NaS0.J and evaporated. The residue was dissolved m 
CH2Cl, (50 ml), dried (anhydrous Na,SO,) and evaporated. and the 
restdue distilled at 150°C and 10 mm. Yield of 8. Scheme 2: 1.95 g, 
57.4%. 
2.2.3. DL-[1,1,2,3,3-2Hs]-l-Aminopropan-2.3-diol (9. Scheme 2) 
The isopropylidene derivative (8, Scheme 2) was dissolved m 
tetrahydrofuran (5 ml), the solution was cooled to 0°C and cont. HCl 
(2 ml) was added. The mixture was refluxed 30 min, cooled to room 
temperature, neutralized by addition of solid K,CO, and evaporated 
in vacua. The residual oil was extracted with hot absolute ethanol 
(5 x 3 ml), the extracts were combined, cooled, filtered and evapo- 
rated. The product (9, Scheme 2) was obtained as an 011 which was 
used without further purification. 
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Scheme 2. Synthesis of deute~um-la~lled I-aminopropan-2,3-dial(9). 
2.3. Incorporation studies with DL-[1,1,2,3.3-‘H,]-I-aminopropan- 2,3- 
dial (9, Scheme 2 j 
A culture of Escherichia rob B WG2 was incubated, as described 
earlier [l], with o-giucose as the general carbon source, in the presence 
of ~~-[~,l,2,3,3-~H~]-l-aminopropan-2,3-diol(9, Scheme 2). Pyridoxol 
hydrochloride was Isolated, after addition of natural abundance pyri- 
doxol hydrochloride as carrier, and was purified by column and TLC, 
followed by high vacuum subhmation [I]. The *H NMR spectrum of 
the isolated sample of pyridoxol hydrochloride (ca. 2.0 mg in 60 _uI of 
methanol, saturated solution) was recorded on a Bruker AM 500 
spectrometer. No deuterium enrichment was detected. 
3. RESULTS AND DISCUSSION 
A culture of E. coli B WG2 was incubated with a 
sample of DL-l-aminopro~an-2,3-diol (9, Scheme 2), in 
which all non-exchangeable hydrogen atoms had been 
replaced by deuterium. An attempt o detect incorpora- 
tion of deuterium from this substrate, into the C-unit, 
C-5’, -5, -6, of pyridoxol, was unsuccessful. No deu- 
terium was detected by NMR spectrometry in the sam- 
ple of pyridoxol hydrochlo~de that was isolated from 
the culture. Whilst it is unwise to draw definitive infer- 
ences from negative results, we nevertheless conclude 
that 1-aminopropan-2,3-diol is not an intermediate of 
pyridoxol biosynthesis since, in a parallel experiment, 
under similar experimental conditions, a deuterium-la- 
belled sampfe of D-I-deoxyxylu~ose (1, Scheme 1) had 
yielded pyridoxol hydrochloride which showed the pre- 
dicted non-random distribution of deuterium [141, indi- 
cating that D-1-deoxyxylulose had indeed served as the 
precursor of the other fragment of pyridoxol, the Cg- 
unit, C-2’,-2,-3,-4,-4’. 
Confi~ato~ evidence for the non-incorporation of 
DL-1-aminopropan-2,3-diol into pyridoxol came from 
another experiment in which mutants blocked in pyri- 
doxal biosynthesis were grown in the presence of this 
compound. The mutants tested represented four linkage 
groups (pdx A, pdx B, pdx C (i.e. ser C), and pdx J) 
coding for enzymes involved in pyridoxal bios~thesis 
I1 51. DL-I -Aminopropan-2,3-diol did not support 
growth of any of these mutants. Thus, another rational- 
ization of the two modes of derivation of the C,-unit, 
C-5’,-5,-6, of pyridoxol must be sought. 
A parallel set of growth experiments in which 4-hy- 
droxy-L-threonine (3, Scheme 1) was tested as the sub- 
strate led to entirely different results. The compound 
was found to support growth of two mutants belonging 
to the pdx C linkage group (E coli AT 3143 and E. coli 
WG 1145) and of two mutants belonging to the pdx B 
linkage group (E. co/i WG 3 and E. coli WG 1012). By 
contrast, no growth response to 4-hydroxy-L-threonine 
was observed with mutants of the pdx A (WC 25) and 
pdx J (AT 3208) linkage groups. 
The results of these growth experiments are presented 
in Fig. 1, where they are compared to growth in the 
presence of pyridoxal. The data are plotted on a log/log 
scale. When pyridoxal served as the substrate, the 
growth curves were essentially linear, wheras they were 
non-linear with 4-hydroxy-t,-threonine. This may indi- 
cate that the growth response of E. coli to this amino 
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acid reflects a balance between the precursor function 
and its anti-metabolic properties [9]. 
The finding that 4-hydroxy-L-threonine sustains the 
growth of several pdx mutants of E. coli is the first direct 
evidence in support of the view [7] that this amino acid 
serves as a precursor of vitamin B,. Furthermore, the 
finding is in agreement with the observation derived 
from genetic experiments [16] which led to the conclu- 
sion that genes of the linkage groups pdx B and C are 
implicated in the synthesis of 4-hydroxy-L-threonine, 
whereas genes of the linkage groups pdx A and pdx J 
are involved in the reactions that lead to the formation 
of the pyridine ring of vitamin B,. 
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